A Study of the Effectiveness and Safety of Topiramate Compared With a Standard Therapy in Patients Newly Diagnosed With Epilepsy

NCT00236717 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
865
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.